Man Group PLC Edwards Lifesciences Corp Transaction History

Man Group PLC

$35.6 Billion
Q4 2024

A detailed history of Man Group PLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Man Group PLC holds 559,450 shares of EW stock, worth $39.4 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

559,450

Previous 442,922 26.31%

Holding current value

$39.4 Million

Previous $29.2 Million 41.7%

% of portfolio

0.12%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$64.54 - $75.92 $7.52 Million - $8.85 Million	116,528 Added 26.31%	559,450 $41.4 Million
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $24.4 Million - $38.4 Million	-409,188 Reduced 48.02%	442,922 $29.2 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $33.9 Million - $37.9 Million	401,966 Added 89.3%	852,110 $78.7 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $7.75 Million - $10.2 Million	106,820 Added 31.11%	450,144 $43 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $67.9 Million - $85.6 Million	-1,100,649 Reduced 76.22%	343,324 $26.2 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $63.2 Million - $85.2 Million	912,105 Added 171.49%	1,443,973 $100 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $6.86 Million - $7.95 Million	-84,304 Reduced 13.68%	531,868 $50.2 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $33.8 Million - $38.4 Million	-454,543 Reduced 42.45%	616,172 $51 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $15.9 Million - $20.3 Million	232,636 Added 27.76%	1,070,715 $79.9 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $15.2 Million - $19.8 Million	-184,951 Reduced 18.08%	838,079 $69.3 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $18.1 Million - $26.8 Million	208,894 Added 25.66%	1,023,030 $97.3 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $6 Million - $7.56 Million	-58,869 Reduced 6.74%	814,136 $95.8 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $36.9 Million - $45.3 Million	-346,894 Reduced 28.44%	873,005 $113 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $4.46 Million - $5.31 Million	-43,295 Reduced 3.43%	1,219,899 $138 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $69.6 Million - $86.9 Million	829,870 Added 191.51%	1,263,194 $131 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $3.94 Million - $4.55 Million	-50,139 Reduced 10.37%	433,324 $36.2 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $23.3 Million - $29.6 Million	-324,379 Reduced 40.15%	483,463 $44.1 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $4.97 Million - $6.46 Million	-73,929 Reduced 8.38%	807,842 $64.5 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $39.8 Million - $53.2 Million	691,399 Added 363.18%	881,771 $60.9 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $1.49 Million - $2.3 Million	-28,362 Reduced 12.97%	190,372 $35.9 Million
Q4 2019 Feb 18, 2020	BUY	$71.7 - $82.09 $13.3 Million - $15.2 Million	185,277 Added 553.78%	218,734 $51 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $823,415 - $1.01 Million	-13,378 Reduced 28.56%	33,457 $7.36 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $1.04 Million - $1.21 Million	-18,737 Reduced 28.57%	46,835 $8.65 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $34,289 - $45,859	716 Added 1.1%	65,572 $12.5 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $5.02 Million - $6.16 Million	-108,138 Reduced 62.51%	64,856 $9.93 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $3.11 Million - $3.95 Million	68,023 Added 64.8%	172,994 $30.1 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $456,677 - $551,885	10,758 Added 11.42%	104,971 $15.3 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $3.5 Million - $4.47 Million	94,213 New	94,213 $13.1 Million

Others Institutions Holding EW

# of Institutions

1,384

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account